163 related articles for article (PubMed ID: 15144934)
21. Role of carvedilol in atrial fibrillation: insights from clinical trials.
Gheorghiade M; Lukas MA
Am J Cardiol; 2004 May; 93(9A):53B-7B. PubMed ID: 15144939
[TBL] [Abstract][Full Text] [Related]
22. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
Am Heart J; 2007 Jan; 153(1):82.e1-11. PubMed ID: 17174643
[TBL] [Abstract][Full Text] [Related]
23. Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US Carvedilol Heart Failure Trials Program.
Joglar JA; Acusta AP; Shusterman NH; Ramaswamy K; Kowal RC; Barbera SJ; Hamdan MH; Page RL
Am Heart J; 2001 Sep; 142(3):498-501. PubMed ID: 11526364
[TBL] [Abstract][Full Text] [Related]
24. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
[TBL] [Abstract][Full Text] [Related]
25. Carvedilol for heart failure: more than just a beta-blocker?
Cleland JG
Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):493-7. PubMed ID: 10193451
[TBL] [Abstract][Full Text] [Related]
26. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.
Rouleau JL; Roecker EB; Tendera M; Mohacsi P; Krum H; Katus HA; Fowler MB; Coats AJ; Castaigne A; Scherhag A; Holcslaw TL; Packer M;
J Am Coll Cardiol; 2004 Apr; 43(8):1423-9. PubMed ID: 15093878
[TBL] [Abstract][Full Text] [Related]
27. Ventricular remodeling in heart failure and the effect of beta-blockade.
Udelson JE
Am J Cardiol; 2004 May; 93(9A):43B-8B. PubMed ID: 15144937
[TBL] [Abstract][Full Text] [Related]
28. Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry.
Franciosa JA; Massie BM; Lukas MA; Nelson JJ; Lottes S; Abraham WT; Fowler M; Gilbert EM; Greenberg B;
Am Heart J; 2004 Oct; 148(4):718-26. PubMed ID: 15459606
[TBL] [Abstract][Full Text] [Related]
29. Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure.
Tarantini L; Cioffi G; Opasich C; Di Lenarda A; Pulignano G; Del Sindaco D; De Feo S; Stefenelli C; Russo P; Catania G
Ital Heart J; 2004 Jun; 5(6):441-9. PubMed ID: 15320569
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group.
Cohn JN; Fowler MB; Bristow MR; Colucci WS; Gilbert EM; Kinhal V; Krueger SK; Lejemtel T; Narahara KA; Packer M; Young ST; Holcslaw TL; Lukas MA
J Card Fail; 1997 Sep; 3(3):173-9. PubMed ID: 9330125
[TBL] [Abstract][Full Text] [Related]
31. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
[TBL] [Abstract][Full Text] [Related]
32. [Severe heart failure. Carvedilol lowers mortality].
MMW Fortschr Med; 2001 Mar; 143(9):58. PubMed ID: 11288541
[No Abstract] [Full Text] [Related]
33. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
34. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.
Krum H; Sackner-Bernstein JD; Goldsmith RL; Kukin ML; Schwartz B; Penn J; Medina N; Yushak M; Horn E; Katz SD
Circulation; 1995 Sep; 92(6):1499-506. PubMed ID: 7664433
[TBL] [Abstract][Full Text] [Related]
35. [The effectiveness of carvedilol in heart failure].
Kárpáti K; Brodszky V; Farsang C; Jermendy G; Vándorfi G; Zámolyi K; Gulácsi L
Orv Hetil; 2006 Oct; 147(40):1931-7. PubMed ID: 17111685
[TBL] [Abstract][Full Text] [Related]
36. Special considerations for carvedilol use in heart failure.
Yancy CW
Am J Cardiol; 2004 May; 93(9A):64B-8B. PubMed ID: 15144941
[TBL] [Abstract][Full Text] [Related]
37. The Initiation Management Predischarge Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) Study: design and implications.
Gattis WA; O'Connor CM; Gheorghiade M
Rev Cardiovasc Med; 2002; 3 Suppl 3():S48-54. PubMed ID: 12447162
[TBL] [Abstract][Full Text] [Related]
38. Randomized trial of carvedilol in treatment of congestive heart failure.
Singer RB
J Insur Med; 1997; 29(2):82-90. PubMed ID: 10169635
[TBL] [Abstract][Full Text] [Related]
39. Carvedilol [Coreg].
Kukin M
Compr Ther; 1997 Sep; 23(9):617-20. PubMed ID: 9285163
[No Abstract] [Full Text] [Related]
40. Carvedilol in the failing heart.
Lombardi WL; Gilbert EM
Clin Cardiol; 2001 Dec; 24(12):757-66. PubMed ID: 11768738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
